Kodiak Sciences Inc (KOD)
6.51
+0.32
(+5.17%)
USD |
NASDAQ |
Nov 25, 13:19
Kodiak Sciences Enterprise Value: 127.88M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 127.88M |
| November 21, 2024 | 112.62M |
| November 20, 2024 | 106.83M |
| November 19, 2024 | 98.93M |
| November 18, 2024 | 99.99M |
| November 15, 2024 | 93.15M |
| November 14, 2024 | 81.04M |
| November 13, 2024 | 91.57M |
| November 12, 2024 | 69.46M |
| November 11, 2024 | 83.15M |
| November 08, 2024 | 61.05M |
| November 07, 2024 | 55.26M |
| November 06, 2024 | 52.63M |
| November 05, 2024 | 32.63M |
| November 04, 2024 | 7.369M |
| November 01, 2024 | 4.211M |
| October 31, 2024 | 2.106M |
| October 30, 2024 | 9.997M |
| October 29, 2024 | 8.945M |
| October 28, 2024 | -1.580M |
| October 25, 2024 | -1.054M |
| October 24, 2024 | -17.37M |
| October 23, 2024 | -11.58M |
| October 22, 2024 | -5.790M |
| October 21, 2024 | -4.737M |
| Date | Value |
|---|---|
| October 18, 2024 | -7.368M |
| October 17, 2024 | -24.21M |
| October 16, 2024 | -39.99M |
| October 15, 2024 | -46.31M |
| October 14, 2024 | -45.78M |
| October 11, 2024 | -48.41M |
| October 10, 2024 | -56.31M |
| October 09, 2024 | -59.99M |
| October 08, 2024 | -58.41M |
| October 07, 2024 | -57.89M |
| October 04, 2024 | -57.89M |
| October 03, 2024 | -61.04M |
| October 02, 2024 | -59.99M |
| October 01, 2024 | -61.04M |
| September 30, 2024 | -60.52M |
| September 27, 2024 | -79.27M |
| September 26, 2024 | -76.64M |
| September 25, 2024 | -82.43M |
| September 24, 2024 | -81.90M |
| September 23, 2024 | -87.16M |
| September 20, 2024 | -80.32M |
| September 19, 2024 | -83.48M |
| September 18, 2024 | -79.27M |
| September 17, 2024 | -78.22M |
| September 16, 2024 | -78.22M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-410.14M
Minimum
May 11 2022
7.441B
Maximum
Dec 24 2020
1.526B
Average
-0.1719M
Median
Enterprise Value Benchmarks
| Pfizer Inc | 202.30B |
| Regeneron Pharmaceuticals Inc | 73.29B |
| Acumen Pharmaceuticals Inc | -29.80M |
| NovaBay Pharmaceuticals Inc | 2.608M |
| Palatin Technologies Inc | 16.38M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -43.95M |
| Total Expenses (Quarterly) | 46.63M |
| EPS Diluted (Quarterly) | -0.84 |
| Earnings Yield | -56.07% |